1M6MYTD1Y5YMAX
Loading quotes...
Forecast
There is no analyst data available for this company.
News Go to news feed
There is currently no news available for this company. We are working on adding more providers to change this.
Financials
| (EUR) | June 2026 | |
|---|---|---|
| Revenue | 0 | - |
| Gross profit | -17.21K | 192.26% |
| Net profit | -610.15K | 70.16% |
| EBITDA | -565.49K | 65.31% |
Fundamentals
| Metric | Value |
|---|---|
Market capitalization | €135.58M |
Number of shares | 9.29M |
52-week high/low | €22.04 - €2.35 |
| Dividends | No |
Beta | 1.10 |
P/E ratio | -70.00 |
PEG ratio | 0.61 |
P/B ratio | 6.94 |
P/S ratio | 0.00 |
Company profile
Medinice S.A. bietet medizinische Lösungen für die Kardiologie und Herzchirurgie an. Das Unternehmen unterstützt Wissenschaftler bei der Kommerzialisierung von Produkten, einschließlich Prototyping, klinische Studien und Zertifizierung sowie Produktvertrieb. Medinice S.A. wurde im Jahr 2012 gegründet und hat seinen Sitz in Warschau, Polen.
| Name | JILIN ELECTRIC POWER A |
| CEO | Sanjeev Choudhary |
| Headquarters | Warsaw,
sk Poland |
| Website | |
| IPO | 09/01/2018 |
| Employees | 10 |
Deep Dive
Ticker symbols
| Exchange | Symbol |
|---|---|
Wse | ICE.WA |
Warschau | ICE.WA |
Discover assets
Shareholders of JILIN ELECTRIC POWER A also invest in the following assets
